1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow QLS-111 ophthalmic vehicle solution: new trials by email Literature Review of QLS-111 ophthalmic vehicle solution trials Research Report on QLS-111 ophthalmic vehicle solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients Experimental: QLS-111 ophthalmic solution, (0.015%), Experimental: QLS-111 ophthalmic solution, (0.03%), Experimental: QLS-111 ophthalmic solution, (0.075%) - Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes | Phase 2 | Completed | Qlaris Bio, Inc. | 63 | 2024-03-05 | 2025-01-20 |
Glaucoma (1) · Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
Qlaris Bio, Inc. (1)
United States (1)
Lisa Brandano (1)